Recently, heterozygous SMCHD1 mutations were identified in patients with Bosma arhinia microphthalmia syndrome (BAMS), an extremely rare syndrome whose triad is the absence of the nose, microphthalmia, and IHH16–18. Here, SMCHD1 is linked to microphthalmia.